Jin Hyoung Kang

The transcriptional landscape and mutational profile of lung adenocarcinoma

Jeong‐Sun Seo, Young Seok Ju, Won‐Chul Lee et al. · Genome Research · 2012 · 593 citations · Full text

Medicine, Genetics, Oncology +17

A transforming <i>KIF5B</i> and <i>RET</i> gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing

Young Seok Ju, Won‐Chul Lee, Jong-Yeon Shin et al. · Genome Research · 2011 · 483 citations · Full text

Medicine, Genetics, Oncology +17

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim et al. · Journal of Clinical Oncology · 2015 · 258 citations · Full text

Medicine, Oncology, Radiation Oncology +17

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer

Keunchil Park, Chong‐Jen Yu, Sang-We Kim et al. · JAMA Oncology · 2015 · 230 citations

Medicine, Oncology, Pharmacology +13

A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy

Seo‐Young Park, M.-H. Lee, Minjung Seong et al. · Annals of Oncology · 2020 · 192 citations · Full text

Medicine, Oncology, Pharmacology +17